TD Cowen Initiates Coverage On Hims & Hers Health with Outperform Rating, Announces Price Target of $11
Portfolio Pulse from richadhand@benzinga.com
TD Cowen analyst Jonna Kim initiates coverage on Hims & Hers Health (NYSE:HIMS) with an Outperform rating and a price target of $11.
July 28, 2023 | 12:39 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Hims & Hers Health receives an Outperform rating from TD Cowen with a price target of $11.
The Outperform rating from TD Cowen indicates a positive outlook for Hims & Hers Health. The price target of $11 suggests that the analyst believes the stock has potential for growth. This could lead to increased investor interest and a potential rise in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100